Publication | Open Access
Oral immunotherapy in alpha‐gal red meat allergy: Could specific <scp>IgE</scp> be a potential biomarker in monitoring management?
12
Citations
32
References
2023
Year
Our study showed the long-term safety and efficacy of alpha-gal OIT. Additionally, alpha-gal sIgE seems to be a potential biomarker to monitor OIT.
| Year | Citations | |
|---|---|---|
Page 1
Page 1